Previous close | 27.08 |
Open | 27.38 |
Bid | 26.99 x 800 |
Ask | 27.05 x 1000 |
Day's range | 26.32 - 27.66 |
52-week range | 15.58 - 48.40 |
Volume | |
Avg. volume | 177,753 |
Market cap | 719.135M |
Beta (5Y monthly) | 1.00 |
PE ratio (TTM) | N/A |
EPS (TTM) | -2.04 |
Earnings date | 27 Feb 2023 - 03 Mar 2023 |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | 49.63 |
FRIENDSWOOD, Texas, January 23, 2023--Castle's medical director, Matthew Goldberg, M.D., F.A.A.D., will present at the Precision Medicine World Conference (PMWC®) 2023 on Jan. 25.
FRIENDSWOOD, Texas, January 17, 2023--Castle is sharing new data supporting the clinical value of their skin cancer tests at the 2023 Winter Clinical Dermatology Conference - Hawaii®.
FRIENDSWOOD, Texas, January 09, 2023--Castle Biosciences today announced certain unaudited preliminary performance results for the fourth quarter and full-year ended Dec. 31, 2022.